Role of Fcγ receptors in HER2-targeted breast cancer therapy
Several therapeutic monoclonal antibodies (mAbs), including those targeting epidermal growth factor receptor, human epidermal growth factor receptor 2 (HER2), and CD20, mediate fragment crystallizable gamma receptor (FcγR)–dependent activities as part of their mechanism of action. These activities i...
Saved in:
| Main Authors: | Hope S Rugo, Antonino Musolino, William J Gradishar, Jeffrey L Nordstrom, Edwin P Rock, Fernanda Arnaldez, Mark D Pegram |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2022-01-01
|
| Series: | Journal for ImmunoTherapy of Cancer |
| Online Access: | https://jitc.bmj.com/content/10/1/e003171.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Expert consensus on treating HR+/HER2- metastatic breast cancer based on real-world practice patterns observed in the RETRACT survey of US oncologists
by: Hope S. Rugo, et al.
Published: (2025-08-01) -
Evidence of variable human Fcγ receptor-Fc affinities across differentially-complexed IgG
by: Andrew R. Crowley, et al.
Published: (2023-12-01) -
Interactions of the anti-FcRn monoclonal antibody, rozanolixizumab, with Fcγ receptors and functional impact on immune cells in vitro
by: Omar S. Qureshi, et al.
Published: (2024-12-01) -
Human Fcγ-receptors selectively respond to C-reactive protein isoforms
by: Anna Henning, et al.
Published: (2025-05-01) -
Fcγ-receptor-IIIA bioactivity of circulating and synovial immune complexes in rheumatoid arthritis
by: Hanns-Martin Lorenz, et al.
Published: (2024-09-01)